

[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
David Macdonald Reiterated (THC) at Strong Buy and Held Target at $92 on, Nov 20th, 2023
David Macdonald of Truist Securities, Reiterated "Tenet Healthcare Corporation" (THC) at Strong Buy and Held Target at $92 on, Nov 20th, 2023.
David has made no other calls on THC in the last 4 months.
There are 12 other peers that have a rating on THC. Out of the 12 peers that are also analyzing THC, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $89 on, Tuesday, August 1st, 2023
These are the ratings of the 11 analyists that currently disagree with David
- Calvin Sternick of "JP Morgan" Maintained at Buy with Decreased Target to $81 on, Friday, November 17th, 2023
- Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $85 on, Tuesday, November 14th, 2023
- Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $85 on, Thursday, November 9th, 2023
- Andrew Mok of "UBS" Maintained at Strong Buy with Decreased Target to $94 on, Thursday, November 2nd, 2023
- John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $90 on, Wednesday, November 1st, 2023
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $77 on, Tuesday, October 31st, 2023
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $72 on, Tuesday, October 31st, 2023
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $71 on, Friday, October 20th, 2023
- Sarah James of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $94 on, Thursday, September 14th, 2023
- A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Wednesday, August 2nd, 2023
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, August 1st, 2023
Contributing Sources